1. E. Lamb, S. Lodhi and H.-U. Meier-Kriesche Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal. American Journal of Transplantation 2011; 11: 450–462
  2. Wang JH, Skeans MA, Israni AK. Current Status of Kidney Transplant Outcomes: Dying to Survive. Adv Chronic Kidney Dis. 2016 Sep;23(5):281-286.
  3. Trends in 1-, 5-, & 10-year kidney transplant graft survival, 1999-2015 (unadjusted) USA- Anual Report 2018. USRDS Figure 6.25. Volume 2: End-Stage Renal Disease in the United States. Accessed on January 2019
  4. Registre de malalts renals de Catalunya. Informe estadístic 2016. Barcelona: Servei Català de la Salut. Organització Catalana de Trasplantaments (OCATT)
  5. Madhav C. Menon, Barbara Murphy, and Peter S. Heeger. Moving Biomarkers toward Clinical Implementation in Kidney Transplantation. J Am Soc Nephrol 2017 28: 735–747
  6. Kurata Y, M Kato, T Kuzuya, Y Miwa, K Iwasaki, M Haneda. Pretransplant Pharmacodynamic Analysis of Immunosuppressive agents using CFSE based T cell proliferation assay. Clinical Pharmacology & Therapeutics 2009; 86 (3): 285-289
  7. Gulimire Muhetaer, Hironori Takeuchi, Sakae Unezaki, Shigeyuki Kawachi, Hitoshi Iwamoto, Yuki Nakamura et al.Clinical Significance of Peripheral Blood Lymphocyte Sensitivity to Glucocorticoids for the Differentiation of High-risk Patients With Decreased Allograft Function After Glucocorticoid Withdrawal in Renal Transplantation. Clinical Therapeutic 2014;36 (8): 1264-1272
  8. Francis DM, Dumble LJ, Bowes L, Clunie GJ, Macdonald IM. Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. 1988 Dec;46(6):853-7.
  9. Aurelie Premaud, Matthieu Filloux, Philippe Gatault , Antoine Thierry , Matthias Büchler, Eliza Munteanu  et al.  An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.  PLoS ONE 12(7): e0180236. https://doi. org/10.1371/journal.pone.0180236